Search research articles
Contact Us
Filters
Showing results (11-20 of 110) with videos related to
Page
of 11
Sort By:
Expert Opinion on Drug Discovery
|
March 20, 2013
Humanised mouse models in drug discovery for skin inflammation
Frederik H Igney, Khusru Asadullah, Thomas M Zollner
Laryngologie, Rhinologie, Otologie
|
February 1, 1977
[Determination of the impaired ear's frequency selectivity using psychoacoustical tuning curves (author's transl)]
K Schorn, H Wurzer, M Zollner, et al.
Ernst Schering Research Foundation Workshop
|
November 6, 2004
Acute and chronic models of allergic contact dermatitis: advantages and limitations
T M Zollner, F H Igney, K Asadullah
Experimental Dermatology
|
December 22, 2006
Targeting leukocyte trafficking to inflamed skin: still an attractive therapeutic approach?
Thomas M Zollner, Khusru Asadullah, Michael P Schön
The Journal of Investigative Dermatology
|
January 8, 2004
The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders
Michael P Schön, Thomas M Zollner, W Henning Boehncke
Contact Dermatitis
|
July 1, 1996
Type IV allergy to natural hirudin confirmed by in vitro stimulation with recombinant hirudin
T M Zollner, H Gall, H Völpel, et al.
Free Radical Biology & Medicine
|
February 22, 2001
Redox-modulated pathways in inflammatory skin diseases
J Fuchs, T M Zollner, R Kaufmann, et al.
Anticancer Research
|
July 1, 1993
Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose
T M Zollner, H G Zhu, F A Anderer
Expert Opinion on Therapeutic Targets
|
July 20, 2006
Fatalities in natalizumab treatment--a 'no go' for leukocyte recirculation approaches?
Yi-Yang Yvonne Li, H Daniel Perez, Thomas M Zollner
Nature
|
February 29, 1996
Pulling the trigger on psoriasis
W H Boehncke, D Dressel, T M Zollner, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 110) with videos related to
Sort By:
Page
of 11
Expert Opinion on Drug Discovery
|
March 20, 2013
Humanised mouse models in drug discovery for skin inflammation
Frederik H Igney, Khusru Asadullah, Thomas M Zollner
Laryngologie, Rhinologie, Otologie
|
February 1, 1977
[Determination of the impaired ear's frequency selectivity using psychoacoustical tuning curves (author's transl)]
K Schorn, H Wurzer, M Zollner, et al.
Ernst Schering Research Foundation Workshop
|
November 6, 2004
Acute and chronic models of allergic contact dermatitis: advantages and limitations
T M Zollner, F H Igney, K Asadullah
Experimental Dermatology
|
December 22, 2006
Targeting leukocyte trafficking to inflamed skin: still an attractive therapeutic approach?
Thomas M Zollner, Khusru Asadullah, Michael P Schön
The Journal of Investigative Dermatology
|
January 8, 2004
The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders
Michael P Schön, Thomas M Zollner, W Henning Boehncke
Contact Dermatitis
|
July 1, 1996
Type IV allergy to natural hirudin confirmed by in vitro stimulation with recombinant hirudin
T M Zollner, H Gall, H Völpel, et al.
Free Radical Biology & Medicine
|
February 22, 2001
Redox-modulated pathways in inflammatory skin diseases
J Fuchs, T M Zollner, R Kaufmann, et al.
Anticancer Research
|
July 1, 1993
Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose
T M Zollner, H G Zhu, F A Anderer
Expert Opinion on Therapeutic Targets
|
July 20, 2006
Fatalities in natalizumab treatment--a 'no go' for leukocyte recirculation approaches?
Yi-Yang Yvonne Li, H Daniel Perez, Thomas M Zollner
Nature
|
February 29, 1996
Pulling the trigger on psoriasis
W H Boehncke, D Dressel, T M Zollner, et al.
Page
of 11